These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37179589)
1. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults. Subhaharan D; Ramaswamy PK; Willmann L; Moattar H; Bhullar M; Ishaq N; Dorrington A; Shukla D; McIvor C; Edwards J; Mohsen W World J Gastroenterol; 2023 Apr; 29(16):2469-2478. PubMed ID: 37179589 [TBL] [Abstract][Full Text] [Related]
2. Prospective validation of AIIMS index as a predictor of steroid failure in patients with acute severe ulcerative colitis. Sahu P; Jain S; Kedia S; Vuyyuru SK; Sahni P; Sharma R; Panwar R; Das P; Gupta V; Makharia G; Travis S; Ahuja V Indian J Gastroenterol; 2022 Jun; 41(3):273-283. PubMed ID: 35474175 [TBL] [Abstract][Full Text] [Related]
3. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial. Choy MC; Li Wai Suen CFD; Con D; Boyd K; Pena R; Burrell K; Rosella O; Proud D; Brouwer R; Gorelik A; Liew D; Connell WR; Wright EK; Taylor KM; Pudipeddi A; Sawers M; Christensen B; Ng W; Begun J; Radford-Smith G; Garg M; Martin N; van Langenberg DR; Ding NS; Beswick L; Leong RW; Sparrow MP; De Cruz P Lancet Gastroenterol Hepatol; 2024 Nov; 9(11):981-996. PubMed ID: 39236736 [TBL] [Abstract][Full Text] [Related]
4. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Sebastian S; Walker GJ; Kennedy NA; Conley TE; Patel KV; Subramanian S; Kent AJ; Segal JP; Brookes MJ; Bhala N; Gonzalez HA; Hicks LC; Mehta SJ; Lamb CA; Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):271-281. PubMed ID: 33545083 [TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy. Powar MP; Martin P; Croft AR; Walsh A; Petersen D; Stevenson AR; Lumley JW; Stitz RW; Radford-Smith GL; Clark DA Colorectal Dis; 2013 Mar; 15(3):374-9. PubMed ID: 22849324 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study. Festa S; Scribano ML; Pugliese D; Bezzio C; Principi M; Ribaldone DG; Allocca M; Mocci G; Bodini G; Spagnuolo R; Vernia P; Mazzuoli S; Costa F; Barberio B; Cosintino R; Zerboni G; Aratari A; Armuzzi A; Papi C United European Gastroenterol J; 2021 May; 9(4):507-516. PubMed ID: 33259773 [TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis. Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroid exposure prior to admission and predicting need for rescue therapy in acute severe ulcerative colitis. Barnes A; Spizzo P; Mountifield R Intern Med J; 2022 May; 52(5):828-833. PubMed ID: 33197107 [TBL] [Abstract][Full Text] [Related]
9. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis. Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297 [TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis. Li Wai Suen CFD; Seah D; Choy MC; De Cruz P Inflamm Bowel Dis; 2024 Aug; 30(8):1389-1405. PubMed ID: 37725044 [TBL] [Abstract][Full Text] [Related]
11. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316 [TBL] [Abstract][Full Text] [Related]
12. Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis. Battat R; Hemperly A; Truong S; Whitmire N; Boland BS; Dulai PS; Holmer AK; Nguyen NH; Singh S; Vande Casteele N; Sandborn WJ Clin Gastroenterol Hepatol; 2021 Mar; 19(3):511-518.e6. PubMed ID: 32348905 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785 [TBL] [Abstract][Full Text] [Related]
14. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis. Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879 [TBL] [Abstract][Full Text] [Related]
15. CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis. Gibson DJ; Hartery K; Doherty J; Nolan J; Keegan D; Byrne K; Martin ST; Buckley M; Sheridan J; Horgan G; Mulcahy HE; Cullen G; Doherty GA J Clin Gastroenterol; 2018 Jul; 52(6):e48-e52. PubMed ID: 28737646 [TBL] [Abstract][Full Text] [Related]
16. Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center. Govani SM; Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Hardiman KM Dig Dis Sci; 2020 Jun; 65(6):1800-1805. PubMed ID: 31748921 [TBL] [Abstract][Full Text] [Related]
17. Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis. Nalagatla N; Falloon K; Tran G; Borren NZ; Avalos D; Luther J; Colizzo F; Garber J; Khalili H; Melia J; Bohm M; Ananthakrishnan AN Clin Gastroenterol Hepatol; 2019 Feb; 17(3):502-509.e1. PubMed ID: 29944926 [TBL] [Abstract][Full Text] [Related]
18. High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival. Chao CY; Al Khoury A; Aruljothy A; Restellini S; Wyse J; Afif W; Bitton A; Lakatos PL; Bessissow T Dig Dis Sci; 2019 Feb; 64(2):518-523. PubMed ID: 30446928 [TBL] [Abstract][Full Text] [Related]
19. Have changing practices in salvage medical options affected colectomy rates in acute severe ulcerative colitis? Clark N; MacIsaac M; Little R; Vogrin S; Harrison M; Tiang T; Keck J; Johnston M; Cunningham G; Wright E; Connell W Intern Med J; 2023 Dec; 53(12):2231-2239. PubMed ID: 36916208 [TBL] [Abstract][Full Text] [Related]